Herpes Simplex
62
2
2
51
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
12 trials with published results (19%)
Research Maturity
51 completed trials (82% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.8%
3 terminated out of 62 trials
94.4%
+7.9% vs benchmark
40%
25 trials in Phase 3/4
24%
12 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 51 completed trials
Clinical Trials (62)
Neonatal Phase 1 Valacyclovir Study
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes
A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years
Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.
Phase III Study of ASP2151 in Herpes Simplex Patients
Open-label Study of ASP2151 in Herpes Simplex Patients
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With Acyclovir
The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children
Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine
A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years
Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease
Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients
Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia
A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children